Preclinical News and Research

RSS
Researchers identify new form of treatment for brain tumor

Researchers identify new form of treatment for brain tumor

DSMB reviews safety data from Phase I/IIa clinical trial of NTCELL for Parkinson’s disease

DSMB reviews safety data from Phase I/IIa clinical trial of NTCELL for Parkinson’s disease

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Multiple sclerosis researchers receive NMSS drug development grant

Multiple sclerosis researchers receive NMSS drug development grant

Using radiation models to improve cancer therapies: an interview with Adrian Treverton, COO of Xstrahl and Jean-Pierre Wery, President of Crown Bioscience

Using radiation models to improve cancer therapies: an interview with Adrian Treverton, COO of Xstrahl and Jean-Pierre Wery, President of Crown Bioscience

DNA vaccine demonstrates potential to prevent and treat deadly MERS coronavirus

DNA vaccine demonstrates potential to prevent and treat deadly MERS coronavirus

Mount Sinai researchers win Best Manuscript Award for research on repair, reversal of heart attack damage

Mount Sinai researchers win Best Manuscript Award for research on repair, reversal of heart attack damage

First patients enrolled in EF-21 Study of NovoTTF Therapy for brain metastases from NSCLC cancer

First patients enrolled in EF-21 Study of NovoTTF Therapy for brain metastases from NSCLC cancer

New evidence shows probiotics offer enormous potential for treatment of depression

New evidence shows probiotics offer enormous potential for treatment of depression

Researchers report long-term benefits of gene therapy in advanced heart failure patients

Researchers report long-term benefits of gene therapy in advanced heart failure patients

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

Extract from bitter melon may have therapeutic qualities to treat head and neck cancer

Extract from bitter melon may have therapeutic qualities to treat head and neck cancer

Paragonix files second 510(k) with FDA for Sherpa Pak Cardiac Transport System

Paragonix files second 510(k) with FDA for Sherpa Pak Cardiac Transport System

Scientists join patients to address Friedreich's Ataxia

Scientists join patients to address Friedreich's Ataxia

Collaborative initiative set up to create precision medicine treatment pathways for advanced cancers

Collaborative initiative set up to create precision medicine treatment pathways for advanced cancers

New microbicide gel formulation shows promise for safe vaginal and rectal administration to prevent HIV

New microbicide gel formulation shows promise for safe vaginal and rectal administration to prevent HIV

Acquired resistance to cancer therapies: an interview with Dr Rajendra Kumari, Chief Scientific Officer at PRECOS

Acquired resistance to cancer therapies: an interview with Dr Rajendra Kumari, Chief Scientific Officer at PRECOS

Mount Sinai researchers successfully test SUMO-1 gene therapy to reverse heart failure

Mount Sinai researchers successfully test SUMO-1 gene therapy to reverse heart failure

Neovasc's Tiara transcatheter mitral valve replacement technology gets US patent

Neovasc's Tiara transcatheter mitral valve replacement technology gets US patent

Merck Serono signs co-development and commercialization agreement for BeiGene-290

Merck Serono signs co-development and commercialization agreement for BeiGene-290

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.